Gül Dölen is known for her research on how psychedelics affect “critical periods” and learning. Now at UC Berkeley, she’s exploring how the brain engages with the drug ecstasy and what it might mean for the future of psychedelic-assisted treatment. Though Gül Dölen’s work focuses primarily on critical periods in the brain that are central...
Tag: <span>Psychedelic</span>
Post
Psychedelic experiences linked with improved sexual function
by Imperial College London Percentage of participants who retrospectively rated decreases or increases in sexual interest, arousal, activity, satisfaction, and anxiety (reversed) after treatment with psilocybin or escitalopram at the 6 weeks follow-up of Study 2. Credit: Scientific Reports (2024). DOI: 10.1038/s41598-023-49817-4Magic mushrooms, LSD and other psychoactive compounds may help to improve sexual function for months...
Post
LSD “off-switch” developed by psychedelic pharmaceutical company
By Rich Haridy Psychedelic pharmaceutical company MindMed has announced the development of a novel compound designed to stop the effects of an LSD experience. The compound is claimed to function as an “off-switch” for LSD, allowing clinicians a way to make psychedelic therapy sessions safer if patients become uncomfortable. The new announcement comes several weeks...
Post
Psychedelic psilocybin therapy for depression granted Breakthrough Therapy status by FDA
In an extraordinary step forward for the psychedelic drug research community, the US Food and Drug Administration (FDA) has just given psilocybin therapy for treatment-resistant depression a Breakthrough Therapy designation. This classification suggests the treatment has demonstrated significant potential in early clinical evidence, allowing the FDA to assist and expedite subsequent development and review processes....